Fluorescence QRH-882260 Peptide Imaging in the Bile Duct
NCT03438435
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
1
Enrollment
OTHER
Sponsor class
Conditions
Cholangiocarcinoma
Interventions
DRUG:
QRH-882260 Heptapeptide
Sponsor
D. Kim Turgeon, MD
Collaborators
[object Object]